When Non-alcoholic fatty liver disease (NAFLD) progresses to nonalcoholic steatohepatitis (NASH), with inflammation and damage to liver cells it can cause fibrosis, cirrhosis and liver failure or cancer. Despite the prevalence of NAFLD and NASH rising, their remains no approved treatments. But studies show that fat and scar tissue can leave the liver, suggesting that they are reversible.
This brochure guides you through complete solutions to support your NASH research efforts.